论文部分内容阅读
目的探究乌司他丁辅助治疗重症肺炎的临床效果。方法选取医院2014年7月-2015年10月接收的重症肺炎患者70例,根据其入院的先后顺序分为对照组和观察组各35例,对照组采用对照组基础进行治疗,观察组在常规方法上使用乌司他丁辅助治疗,观察2组效果并进行比较。结果观察组总有效率为85.71%高于对照组的68.57%(P<0.05),观察组治疗后氧合指数(Pa O2/Fi O1)、心率(HR)、呼吸频率(RR)和白细胞(WBC)改善情况均优于对照组,观察组机械通气时间,住院时间均短于对照组,差异均有统计学意义(P<0.05)。结论采用乌司他丁辅助治疗重症肺炎,促进患者恢复,提高治疗效果,值得临床推广应用。
Objective To investigate the clinical effect of ulinastatin in the treatment of severe pneumonia. Methods Seventy patients with severe pneumonia who were admitted to hospital from July 2014 to October 2015 were divided into control group and observation group according to the order of their admission. 35 patients in control group and control group were treated with control group, Methods Ulinastatin adjuvant therapy, the two groups were observed and compared. Results The total effective rate in the observation group was 85.71%, which was significantly higher than that in the control group (68.57%, P <0.05). PaO2 / Fi O1, HR, respiratory rate and white blood cells WBC) were better than the control group, the observation group, mechanical ventilation time, hospitalization were shorter than the control group, the difference was statistically significant (P <0.05). Conclusion Ulinastatin adjuvant treatment of severe pneumonia, promote patient recovery, improve the therapeutic effect, it is worthy of clinical application.